The Effects of Inhaled Sodium Nitrite on Pulmonary Vascular Impedance in Patients With Pulmonary Hypertension Associated with Heart Failure With Preserved Ejection Fraction

J Card Fail. 2020 Aug;26(8):654-661. doi: 10.1016/j.cardfail.2020.04.006. Epub 2020 May 22.

Abstract

Background: The severity of pulmonary hypertension (PH) is monitored by measuring pulmonary vascular resistance, which is a steady-state measurement and ignores the pulsatile load encountered by the right ventricle (RV). Pulmonary vascular impedance (PVZ) can depict both steady-state and pulsatile forces, and thus may better predict clinical outcomes. We sought to calculate PVZ in patients with PH associated with heart failure with preserved ejection fraction who were administered inhaled sodium nitrite to better understand the acute effects on afterload.

Methods and results: Fourteen patients with PH associated with heart failure with preserved ejection fraction underwent right heart catherization and were administered inhaled sodium nitrite. A Fourier transform was used to calculate PVZ for both before and after nitrite for comparison. Inhaled sodium nitrite decreased characteristic impedance (inversely related to proximal pulmonary artery compliance) and total work performed by the RV. RV efficiency improved, defined by a reduction in the total work divided by cardiac output. There was a mild decrease in pulmonary steady-state resistance after the administration of inhaled sodium nitrite, but this effect was not significant.

Conclusions: PVZ analysis showed administration of inhaled sodium nitrite was associated with an improvement in pulmonary vascular compliance via a decrease in characteristic impedance, more so than pulmonary steady-state resistance. This effect was associated with improved RV efficiency and total work.

Keywords: Pulmonary hypertension; heart failure with preserved ejection fraction; pulmonary vascular compliance; pulmonary vascular impedance.

MeSH terms

  • Electric Impedance
  • Heart Failure* / complications
  • Heart Failure* / drug therapy
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Pulmonary Artery
  • Sodium Nitrite
  • Stroke Volume
  • Vascular Resistance
  • Ventricular Function, Right

Substances

  • Sodium Nitrite